peptuity.
WhatsApp

Goal matrix

Immunity

Every compound we track for this goal.

2 Well researched2 Emerging
VIP 156 RCTsWell researched
Broad, well-documented physiological rolessupported
Intranasal VIP treats chronic inflammatory illnessweak evidence
Thymosin Alpha-1 55 RCTsWell researched
Approved in several countries for chronic hepatitis Bsupported
Modulates T-cell functionsupported
Boosts immunity in healthy peopleweak evidence
LL-37 40 RCTsEmerging
Kills microbes in laboratory modelspreclinical only
A core component of human innate immunitysupported
Treats chronic infections when injectedweak evidence
KPV 0 RCTsEmerging
Reduces inflammation in gut and skin modelsanimal data only
Treats inflammatory bowel disease in humansweak evidence

Other goals

Research use only

All content on Peptuity is provided for research and educational purposes only. Peptuity does not sell, distribute, or facilitate the purchase of any compound, does not provide medical advice, and makes no claims regarding safety or efficacy. Most compounds discussed are not approved for human use by the SFDA or FDA. Always consult a qualified physician.

Ask a question